Humane Milch-Oligosaccharide in aller (Babys) Munde

Barbara Petschacher

doi:10.1055/a-0792-0676

Hebamme, Table of Contents

Hebamme 2018; 31(06): 409-414
DOI: 10.1055/a-0792-0676

CNE Schwerpunkt

Humane Milch-Oligosaccharide in aller (Babys) Munde

Barbara Petschacher

Abstract

Wissenschaftlern weltweit gelingt es zunehmend, die wertvollen Inhaltsstoffe von Muttermilch und ihre große Bedeutung für die Säuglingsgesundheit zu entschlüsseln. Das Institut für Biotechnologie und Bioprozesstechnik der TU Graz forscht zum Thema humane MilchOligosaccharide (HMO). In ihrem Übersichtsartikel erklärt die Autorin bisherige Erkenntnisse über den Aufbau, das Vorkommen und die Wirkungsweise von HMO. Daraus ergeben sich spannende Perspektiven für mögliche zukünftige Anwendungen.

Full Text

References

Literatur
1 Bode L. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology 2012; 22: 1147-1162
2 Zivkovic A, German J, Lebrilla C. et al. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A 2011; , 108 , 4653-4658
3 Kuhn R, Baer H. Die Konstitution der Lacto-N-tetraose. Chem Ber 1956; 89: 504-511
4 Urashima T, Taufik E, Fukuda K. et al. Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals. Biosci Biotechnol Biochem 2013; 77: 455-466
5 Albrecht S, Lane J, Mariño K. et al. A comparative study of free oligosaccharides in the milk of domestic animals. Br J Nutr 2014; 111: 1313-1328
6 Ninonuevo M, Park Y, Yin H. et al. A strategy for annotating the human milk glycome, J Agric Food Chem 2006; , 54: 7471-7480
7 Bode L. The functional biology of human milk oligosaccharides. Early Hum Dev 2015; 91: 619-622
8 Kunz C, Meyer C, Collado M. et al. Influence of gestational age, secretor, and lewis blood group status on the oligosaccharide content of human milk. J Pediatr Gastroenterol Nutr 2017; 64: 789-798
9 Thurl S, Munzert M, Boehm G. et al. Systematic review of the concentrations of oligosaccharides in human milk. Nutr Rev 2017; 75: 920-933
10 Azad M, Robertson B, Atakora F. et al. Human milk oligosaccharide concentrations are associated with multiple fixed and modifiable maternal characteristics, environmental factors, and feeding practices. J Nutr 2018; 148: 1733-1742
11 McGuire M, Meehan C, McGuire M. et al. What’s normal? Oligosaccharide concentrations and profiles in milk produced by healthy women vary geographically. Am J Clin Nutr 2017; 105: 1086-1100
12 Korpela K, Salonen A, Hickman B. et al. Fucosylated oligosaccharides in mother’s milk alleviate the effects of caesarean birth on infant gut microbiota. Sci Rep 2018; 8: 13757
13 Bergström A, Skov T, Bahl M. et al. Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol 2014; 80: 2889-2900
14 Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med 2016; 8: 51
15 Figueroa-Lozano S, de Vos P. Relationship between oligosaccharides and glycoconjugates content in human milk and the development of the gut barrier. Compr Rev Food Sci Food Saf 2018 , early view
16 Kho ZY, Lal SK. The human gut microbiome – A potential controller of wellness and disease. Front Microbiol 2018; 9: 1835
17 Thomson P, Medina D, Garrido D. Human milk oligosaccharides and infant gut bifidobacteria: Molecular strategies for their utilization. Food Microbiol 2018; 75: 37-46
18 Yu Z-T, Nanthakumar N, Newburg D. The human milk oligosaccharide 2′-fucosyllactose quenches Campylobacter jejuni-induced inflammation in human epithelial cells HEp-2 and HT-29 and in mouse intestinal mucosa. J Nutr 2016; 146: 1980-1990
19 Coppa G V, Zampini L, Galeazzi T. et al. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res 2006; 59: 377-382
20 Morozov V, Hansman G, Hanisch F-G. et al. Human milk oligosaccharides as promising antivirals. Mol Nutr Food Res 2018; 62: 1700679
21 Jantscher-Krenn E, Zherebtsov M, Nissan C. et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. 2012; 61: 1417-1425
22 Gonia S, Tuepker M, Heisel T. et al. Human milk oligosaccharides inhibit Candida albicans invasion of human premature intestinal epithelial cells. J Nutr 2015; 145: 1992-1998
23 Lin A, Autran C, Espanola S. et al. Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity. J Infect Dis 2014; 209: 389-398
24 Xiao L, van’t Land B, Engen P. et al. Human milk oligosaccharides protect against the development of autoimmune diabetes in NOD-mice. Sci Rep 2018; 8: 3829
25 Xiao L, Leusink-Muis T, Kettelarij N. et al. Human milk oligosaccharide 2ʹ-Fucosyllactose improves innate and adaptive immunity in an influenza-specific murine vaccination model. Front Immunol 2018; 9: 452
26 Ramani S, Stewart C, Laucirica D. et al. Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection. Nat Commun 2018; 9: 5010
27 Vandenplas Y, Berger B, Carnielli V. et al. Human milk oligosaccharides: 2ʹ-fucosyllactose (2ʹ-FL) and lacto-n-neotetraose (LNnT) in infant formula. Nutrients 2018; 10: 1161
28 Vázquez E, Barranco A, Ramírez M. et al. Effects of a human milk oligosaccharide, 2ʹ-fucosyllactose, on hippocampal long-term potentiation and learning capabilities in rodents. J Nutr Biochem 2015; 26: 455-465
29 Tarr A, Galley J, Fisher S. et al. The prebiotics 3’Sialyllactose and 6’Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence for effects on the gut-brain axis. Brain Behav Immun 2015; 50: 166-177
30 Zehra S, Khambati I, Vierhout M. et al. Human milk oligosaccharides attenuate antigen-antibody complex induced chemokine release from human intestinal epithelial cell lines. J Food Sci 2018; 83: 499-508
31 Elison E, Vigsnaes L, Rindom Krogsgaard L. et al. Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. Br J Nutr 2016; 116: 1356-1368
32 Mezoff E, Hawkins J, Ollberding N. et al. The human milk oligosaccharide 2ʹ-fucosyllactose augments the adaptive response to extensive intestinal. Am J Physiol - Gastrointest Liver Physiol 2016; 310: G427-G438
33 Craft K, Gaddy J, Townsend S. Human Milk Oligosaccharides (HMOs) sensitize group B Streptococcus to Clindamycin, Erythromycin, Gentamicin, and Minocycline on a strain specific basis. ACS Chem Biol 2018; 13: 2020-2026
34 Moro G, Minoli I, Mosca M. et al. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr 2002; 34: 291-295
35 Hoeflinger J, Davis S, Chow J. et al. In vitro impact of human milk oligosaccharides on Enterobacteriaceae growth. J Agric Food Chem 2015; 63: 3295-3302
36 Bych K, Mikš M, Johanson T. et al. Production of HMOs using microbial hosts – from cell engineering to large scale production. Curr Opin Biotechnol 2019; 56: 130-137
37 Marriage B, Buck R, Goehring K. et al. Infants fed a lower calorie formula with 2′FL show growth and 2′FL uptake like breast-fed infants. J Pediatr Gastroenterol Nutr 2015; 61: 649-658
38 Goehring K, Marriage B, Oliver J. et al. Similar to those who are breastfed, infants fed a formula containing 2ʹ-fucosyllactose have lower inflammatory cytokines in a randomized controlled trial. J Nutr 2016; 146: 2559-2566
39 Puccio G, Alliet P, Cajozzo C. et al. Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity. J Pediatr Gastroenterol Nutr 2017; 64: 624-631